What's in the future?The Dec 19 half year report says that CGB...

What's in the future?

The Dec 19 half year report says that CGB bought 80% of the IP of a few "unique medicinal cannabis formulations" from a director for 50 million shares. Now that the coffers are overflowing, perhaps CGB will buy the remaining 20% for an even higher consideration?

" Subject to regulatory approvals CGB intends to investigate raising money directly into PMRPL with the view to independently list PMRPL on the ASX in 2020."
Now that WILL be interesting.